Platelet Volunteers, Longitudinal and Multi-omic Study
NCT07137429 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2026-04-15
Summary
Background:
Platelets are a type of blood cell that play a critical role in bleeding, forming blood clots, and healing. Researchers want to know more about platelets work in healthy people. They want to look at how platelets clump together, how blood clots, and how genes and proteins work. They also want to study how these processes change over time and how they are affected by factors such diet, exercise, weight, and new health problems.
Objective:
To study how platelets function in healthy people.
Eligibility:
Healthy people aged 18 years and older.
Design:
Researchers will review participants medical history. They will ask about the participant s family history and any drugs they take.
Participants will have a clinic visit once every 6 or 7 months for 10 years. Each visit will be 2 to 3 hours.
At each visit, participants will have several tests and procedures:
A physical exam, including vital signs. Hip and ankle circumference will be measured.
Urine collection.
Blood tests. About 10 tablespoons of blood will be drawn. Participants will be asked to fast for 10 hours and avoid drugs like aspirin or Advil for 7 days before each draw. Some of the blood may be used for gene studies. Some may be used to create stem cells for research. Stem cells are cells that can be used to make other types of cells.
Surveys and questionnaires. Participants will answer questions about habitual activity, diet, smoking, drugs and alcohol, sleep, illness, and other health issues. These surveys may be done online, via email, or by phone.
Conditions
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Principal Investigators
-
Andrew D Johnson, Ph.D. · National Heart, Lung, and Blood Institute (NHLBI)
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2026-03-26
- Primary Completion
- 2041-09-15
- Completion
- 2041-09-15
Countries
- United States
Study Locations
More Related Trials
-
Platelet Function With Various Storage Techniques
NCT03338660 ·Status: WITHDRAWN ·Phase: PHASE2
-
Study of Constitutional Platelet Disease
NCT04419987 ·Status: UNKNOWN ·Phase: NA
-
Blood Component Collection From Patients With Rheumatic or Kidney Disease and Healthy Volunteers
NCT00031174 ·Status: TERMINATED
-
Optimizing Platelet Isolation (The Cell Study)
NCT04470505 ·Status: COMPLETED
-
Effects of Recombinant Human Thrombopoietin on Platelet Levels in ICU Patients
NCT05217719 ·Status: UNKNOWN ·Phase: PHASE4
-
Research for Plasma Biomarkers Associated With Fatigue in Thrombocytopenic Patients
NCT06979765 ·Status: RECRUITING ·Phase: NA
-
A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia
NCT04278924 ·Status: COMPLETED ·Phase: PHASE2
-
Assesment of the Functional Activity of Platelets for the Differential Diagnosis of Thrombocytopathies
NCT05654766 ·Status: UNKNOWN
-
The Association Between Platelet Reactivity and Bleeding Risk in Adult ITP
NCT03377439 ·Status: UNKNOWN
-
PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer
NCT04842760 ·Status: UNKNOWN
-
Post-transfusion Platelet Count
NCT02601131 ·Status: COMPLETED
-
Genome-Wide Gene Expression Profiling of Patients With ITP Receiving Thrombopoietin Mimetics
NCT01727999 ·Status: COMPLETED
-
Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution
NCT02145507 ·Status: COMPLETED ·Phase: PHASE1
-
Is Clonal Hematopoiesis of Indeterminate Potential Associated With Unprovoked Pulmonary Embolism?
NCT04711746 ·Status: RECRUITING ·Phase: NA
-
Pathogen Reduction Evaluation & Predictive Analytical Rating Score
NCT02783313 ·Status: COMPLETED ·Phase: NA
-
Study for Validation of In-vitro Turbidometric Platelet Aggregation Assay Using Human Blood in Healthy Volunteers
NCT02071628 ·Status: COMPLETED
-
Cold Versus Room Temperature Storage of Platelets for Bleeding in Hematologic Malignancy - a Pilot Trial
NCT05820126 ·Status: RECRUITING ·Phase: PHASE2
-
Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia
NCT06033300 ·Status: RECRUITING ·Phase: NA
-
Idiopathic Chronic Thrombocytopenia of Undetermined Significance : Pathogenesis and Biomarker
NCT04003220 ·Status: UNKNOWN
-
A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
NCT01440361 ·Status: WITHDRAWN ·Phase: PHASE2
-
Optimal Platelet Dose Strategy for Management of Thrombocytopenia
NCT00128713 ·Status: COMPLETED ·Phase: PHASE3
-
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH)
NCT04272970 ·Status: COMPLETED ·Phase: NA
-
Evaluation of the Efficacy of Platelets Treated With Pathogen Reduction Process
NCT01789762 ·Status: COMPLETED ·Phase: PHASE4
-
Assessment of Whole Blood Cold Stored Platelets
NCT02006368 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety Study of Platelets Treated for Pathogen Inactivation and Stored for Up to Seven Days
NCT00261924 ·Status: COMPLETED ·Phase: PHASE3